Baillie Gifford & Co’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-364,768
| Closed | -$17.1M | – | 275 |
|
|
2024
Q3 | $17.1M | Sell |
364,768
-40,657
| -10% | -$1.91M | 0.01% | 189 |
|
|
2024
Q2 | $21.9M | Buy |
405,425
+9,510
| +2% | +$514K | 0.02% | 176 |
|
|
2024
Q1 | $27M | Sell |
395,915
-26,848
| -6% | -$1.83M | 0.02% | 175 |
|
|
2023
Q4 | $26.5M | Sell |
422,763
-18,300
| -4% | -$1.15M | 0.02% | 177 |
|
|
2023
Q3 | $20M | Buy |
441,063
+197,469
| +81% | +$8.96M | 0.02% | 185 |
|
|
2023
Q2 | $13.7M | Sell |
243,594
-19,757
| -8% | -$1.11M | 0.01% | 204 |
|
|
2023
Q1 | $11.9M | Hold |
263,351
| – | – | 0.01% | 210 |
|
|
2022
Q4 | $10.7M | Sell |
263,351
-25,202
| -9% | -$1.02M | 0.01% | 217 |
|
|
2022
Q3 | $18.9M | Buy |
+288,553
| New | +$18.9M | 0.02% | 189 |
|